← brief for 2026-09-23 · Slowing decline

SGLT2 inhibitors and outcomes in the chronic Post-LVAD phase: a multicenter real-world cohort study.

Article C Peer reviewed Observational

Key takeaways

This study looked at people with heart machines called LVADs. It found that a type of diabetes drug called SGLT2 inhibitors was linked to better outcomes. This is an observational study, so it shows a link, not proof of cause.

Who did this work

Wu JY · Lee KW · Huang SC · Chang HY · Lin YM

Source

Article · PubMed, the drug frontier · 2026 Sep 8
https://pubmed.ncbi.nlm.nih.gov/42774074/